SC

Stempoint Capital Portfolio holdings

AUM $583M
1-Year Est. Return 185.08%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+185.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$583M
AUM Growth
+$86.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
112
New
Increased
Reduced
Closed

Top Buys

1 +$25.6M
2 +$24.6M
3 +$16.2M
4
CNTA
Centessa Pharmaceuticals
CNTA
+$12.6M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$9.9M

Top Sells

1 +$63.7M
2 +$22.2M
3 +$21.1M
4
QURE icon
uniQure
QURE
+$18.5M
5
WVE icon
Wave Life Sciences
WVE
+$15.4M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABVX
1
Abivax
ABVX
$8.78B
$52.8M 9.07%
391,783
+225,510
SRRK icon
2
Scholar Rock
SRRK
$4.52B
$39.1M 6.7%
886,893
+160,689
CNTA
3
Centessa Pharmaceuticals
CNTA
$3.87B
$28.9M 4.95%
1,154,114
+498,729
SNDX icon
4
Syndax Pharmaceuticals
SNDX
$1.86B
$28.1M 4.83%
1,339,379
-26,826
GPCR icon
5
Structure Therapeutics
GPCR
$4.45B
$24.4M 4.19%
351,073
+221,738
ACLX icon
6
Arcellx
ACLX
$6.59B
$21.7M 3.72%
332,860
+321,484
ROIV icon
7
Roivant Sciences
ROIV
$19.9B
$21M 3.6%
966,698
-3,230,489
TERN icon
8
Terns Pharmaceuticals
TERN
$4.57B
$17.3M 2.98%
429,198
+339,581
TWST icon
9
Twist Bioscience
TWST
$2.81B
$16.4M 2.82%
+518,355
IMVT icon
10
Immunovant
IMVT
$5.44B
$16.4M 2.81%
644,959
-944,621
DYN icon
11
Dyne Therapeutics
DYN
$2.66B
$16.3M 2.8%
835,200
+360,588
XENE icon
12
Xenon Pharmaceuticals
XENE
$3.38B
$15.6M 2.68%
348,605
+156,310
SRZN icon
13
Surrozen
SRZN
$245M
$12.7M 2.17%
619,766
-93,697
CELC icon
14
Celcuity
CELC
$4.97B
$11.8M 2.03%
118,333
-18,377
MLYS icon
15
Mineralys Therapeutics
MLYS
$2.26B
$10.5M 1.81%
290,049
+131,937
MDGL icon
16
Madrigal Pharmaceuticals
MDGL
$9.67B
$10.3M 1.77%
17,736
+9,529
ADPT icon
17
Adaptive Biotechnologies
ADPT
$2.47B
$9.85M 1.69%
+606,825
PALI icon
18
Palisade Bio
PALI
$252M
$9.85M 1.69%
+4,192,375
CYTK icon
19
Cytokinetics
CYTK
$7.51B
$9.34M 1.6%
+146,978
EWTX icon
20
Edgewise Therapeutics
EWTX
$3.05B
$8.96M 1.54%
+360,876
DRUG
21
Bright Minds Biosciences
DRUG
$810M
$7.6M 1.3%
+97,340
NKTR icon
22
Nektar Therapeutics
NKTR
$1.91B
$7.54M 1.29%
178,274
+125,073
JNJ icon
23
Johnson & Johnson
JNJ
$595B
$7.24M 1.24%
+35,000
DNLI icon
24
Denali Therapeutics
DNLI
$3.13B
$6.92M 1.19%
419,058
-1,315,601
AMLX icon
25
Amylyx Pharmaceuticals
AMLX
$1.55B
$6.83M 1.17%
565,140
+288,256